"Norethindrone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A synthetic progestational hormone with actions similar to those of PROGESTERONE but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for contraception.
| Descriptor ID |
D009640
|
| MeSH Number(s) |
D04.210.500.668.651.693.651
|
| Concept/Terms |
Norethindrone- Norethindrone
- Norpregneninolone
- Norethisterone
- Ethinylnortestosterone
|
Below are MeSH descriptors whose meaning is more general than "Norethindrone".
Below are MeSH descriptors whose meaning is more specific than "Norethindrone".
This graph shows the total number of publications written about "Norethindrone" by people in this website by year, and whether "Norethindrone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 0 | 2 | 2 |
| 2013 | 1 | 1 | 2 |
| 2014 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Norethindrone" by people in Profiles.
-
Synthetic gestagens exert differential effects on arterial thrombosis and aortic gene expression in ovariectomized apolipoprotein E-deficient mice. Br J Pharmacol. 2014 Nov; 171(22):5032-48.
-
Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1. Maturitas. 2013 Oct; 76(2):129-33.
-
Overexpression of progesterone receptor membrane component 1: possible mechanism for increased breast cancer risk with norethisterone in hormone therapy. Menopause. 2013 May; 20(5):504-10.
-
Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells. Gynecol Endocrinol. 2013 Feb; 29(2):160-3.
-
Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells. Climacteric. 2012 Oct; 15(5):467-72.
MeSH information
